ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1376	National Cancer Institute	Html	en	Cervical Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of cervical cancer.	Obstet Gynecol 0.632265 Ib-IIa cervical cancer 0.622159 cervical carcinoma 0.7714 Invasive cervical cancer 0.634596 cervical lesion 0.589978 cell cervical cancer 0.622655 Radiat Oncol Biol 0.629582 cervical carcinoma patients 0.625359 uterine cervix 0.691758 stage IB 0.622493 oncology group study 0.594527 cervical cancer screening 0.639667 pelvic radiation therapy 0.616405 Natl Cancer Inst 0.715673 early-stage cervical carcinoma 0.617419 cervical cancer 0.919863 advanced cervical carcinoma 0.650637 human papillomavirus infection 0.632755 radical surgery 0.591536 Gynecologic Oncology Group 0.647439 Gynecol Oncol 0.719059 stage cervical cancer 0.656488 human papillomavirus 0.762889 radiation therapy 0.621545 et al. 0.77758	early-stage cervical cancer 0.645908 IB cervical carcinoma 0.685888 advanced cervical cancer 0.71286 cervical cancer patients 0.639703 PUBMED Abstract 0.66552 high-risk cervical cancer 0.623567 Recurrent cervical cancer 0.622873 primary cervical cancer 0.62989 abnormal cervical cancer 0.630972 cervical cancer risk 0.6957 Abstract 0.771164 Clin Oncol 0.627188 invasive cervical carcinoma 0.622845 forecasts cervical cancer 0.63215 Oncol Biol Phys 0.631517 Cervical Cancer Meta-Analysis 0.620594 cervical intraepithelial neoplasia 0.750465 I/II cervical cancer 0.623038 HPV infection 0.611536 squamous cervical carcinoma 0.629261 squamous intraepithelial lesions 0.632419 IIA cervical carcinomas 0.590932 cervical cytologic specimens 0.615306 Wright TC Jr 0.598346	CLICK HERE
1469	National Cancer Institute	Html	en	Adult Central Nervous System Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult central nervous system tumors.	type anaplastic astrocytomas 0.549962 5-year analysis 0.459034 rapid immunohistochemical analysis 0.458442 mutations aids diagnosis 0.4781 adjuvant temozolomide 0.53303 BRAF genetic alterations 0.471994 pontine gliomas 0.467631 concurrent radiation therapy 0.474706 MGMT promoter methylation 0.572789 Radiation Therapy Oncology 0.484458 oligodendroglial tumors 0.468432 adult high-grade glioma 0.464776 Nervous System Tumors 0.717497 Astrocytic Tumors Treatment 0.922097 diffuse astrocytomas 0.480334 prognostic factor 0.47815 patients 0.62456 Primary Central Nervous 0.835704 Tumor Type section 0.826321 low-grade gliomas 0.476475 randomized trials 0.48238 anaplastic gliomas 0.467716 Treatment Option Overview 0.469049 standard systemic chemotherapy 0.485413	mutant tumors 0.500547 malignant gliomas 0.567609 radiation therapy 0.833741 standard chemotherapy agent 0.48857 Lancet Oncol 0.46722 glioblastoma patients 0.504986 Radiation Therapy section 0.489765 deep-seated tumors 0.489355 Glioblastomas treatment section 0.511285 diffuse gliomas 0.494198 CNS tumors 0.489107 strong prognostic factor 0.47196 primary malignant glioma 0.474955 DNA repair enzyme 0.549791 standard local treatment 0.596897 Low-grade tumors 0.493795 oral agent temozolomide 0.522443 pilocytic astrocytomas 0.562223 particular glioma subtypes 0.489447 newly diagnosed glioblastoma 0.602836 activating point mutation 0.473461 Tumors Treatment section 0.972163 mutant-specific IDH1 antibody 0.464835 potential diagnostic utility 0.459778	CLICK HERE
1549	National Cancer Institute	Html	en	Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®)–Patient Version	Brain and spinal cord tumors may be benign (not cancer) or malignant (cancer). Both types cause signs or symptoms and need treatment. Get information about the many kinds of brain and spinal cord tumors, signs and symptoms, tests to diagnose, and treatment in this expert-reviewed summary.	PDQ Childhood Brain 0.257478 cancer treatment 0.297382 spinal column 0.245566 body 0.252077 PDQ cancer information 0.277635 spinal cord tumor 0.378418 clinical trials 0.370146 health care providers 0.249776 Pediatric Treatment Editorial 0.244163 cancer information summary 0.261575 clinical trial 0.273191 Nervous System Tumors 0.243367 High-grade spinal cord 0.281934 recurrent childhood brain 0.283273 newly diagnosed brain 0.237604 NCI PDQ cancer 0.242529 tests 0.251387 brain stem 0.243824 Metastatic tumors 0.243822 Treatment Editorial Board 0.245992 childhood cancer 0.271461 Cord Tumors Treatment 0.28928 General Information section 0.242596 treatment 0.384234 childhood spinal cord 0.316653	cancer cells 0.347188 standard treatment 0.240256 tumor risk group 0.274387 childhood brain 0.596751 spinal tap 0.246398 signs 0.239529 Benign brain tumors 0.275877 treatment clinical trials 0.238797 National Cancer Institute 0.261551 tumor cells 0.240778 Low-grade spinal cord 0.282176 effects cancer treatment 0.24403 new treatment 0.262653 types 0.237657 childhood cancer information 0.249646 childhood brain tumors 0.325204 PDQ summary 0.248201 tumor marker test 0.242818 Spinal cord nerves 0.295114 Malignant brain tumors 0.275792 cancer 0.437578 information 0.284357 spinal cord tumors 0.945242 brain stem controls 0.239043	CLICK HERE
1648	National Cancer Institute	Html	en	Acupuncture (PDQ®)–Patient Version	Expert-reviewed information summary about acupuncture as a treatment for people with cancer or cancer-related disorders.	sham acupuncture 0.790117 cancer treatment 0.64041 real acupuncture 0.712021 States practice acupuncture 0.64678 acupuncture practitioner 0.636806 PDQ cancer information 0.592449 Microwave acupuncture 0.620692 clinical trials 0.757112 acupuncture treatment 0.66786 cancer information summary 0.574467 clinical trial 0.596368 patients 0.696397 cancer patients 0.661009 breast cancer survivors 0.616253 standard care 0.619139 sham acupuncture group 0.64456 acupuncture clinical observation 0.630268 acupuncture needle 0.654731 acupuncture needles 0.653493 hot flashes 0.628474 radiation therapy 0.576978 real acupuncture works 0.632379 randomized clinical trials 0.584867 cancer information 0.604795 additional acupuncture 0.614493	Acupuncture point injection 0.633801 United States 0.574545 Cancer Information Service 0.583177 Laser acupuncture 0.622096 acupuncture points 0.640397 acupuncture point 0.639768 Auricular acupuncture 0.62262 studies 0.661016 National Cancer Institute 0.633121 sham acupuncture groups 0.64373 alternative medicine 0.568566 acupuncture improved xerostomia 0.627172 pain 0.585716 therapy 0.586612 acupuncture practice 0.611162 acupuncture techniques 0.624193 breast cancer 0.617659 traditional Chinese medicine 0.580302 acupuncture methods 0.624551 acupuncture method 0.623018 true acupuncture 0.617235 acupuncture 0.900286 Trigger point acupuncture 0.633788 specific acupuncture point 0.629179	CLICK HERE
1877	National Cancer Institute	Html	es	Tratamiento del linfoma primario del sistema nervioso central (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma primario del sistema nervioso central.	lymphoma collaborative group 0.221499 non-aids primary 0.214603 system lymphoma after 0.212927 cerebral non-Hodgkin lymphoma 0.210841 or intraocular lymphoma 0.212565 Lymphoma Study Group 0.224227 high-dose chemotherapy with 0.225593 International Extranodal Lymphoma 0.221958 intraocular lymphoma 0.239499 with primary cns 0.254535 Primary Brain Tumor 0.210419 high-dose chemotherapy 0.225677 Radiat Oncol Biol 0.211148 Lymphoma Group 0.219295 syndrome-related lymphoma 0.210481 intensive chemotherapy 0.210023 primary cerebral lymphomas 0.210038 central nervous system 0.60114 Extranodal Lymphoma Study 0.223831 patients with primary 0.244525 International Primary Central 0.210485 Ferreri AJ 0.218398 chemotherapy followed 0.215362 chemotherapy with 0.231706 international primary cns 0.215425	Non-AIDS Primary CNS 0.213926 patient with primary 0.21103 primary cns non-Hodgkin 0.214388 primary cns lymphoma 0.988429 recurrent primary cns 0.221546 diagnosed primary cns 0.280123 quimioterapia sistémica 0.213366 System Lymphoma Collaborative 0.212953 Martus P 0.225523 chemotherapy with autologous 0.216514 as primary 0.210335 Primary intraocular lymphoma 0.221058 primary central nervous 0.665308 radiation therapy oncology 0.22435 primary brain 0.216414 Clin Oncol 0.417434 sistema nervioso central 0.287075 Oncol Biol Phys 0.21138 international primary 0.216816 Lymphoma Group Phase 0.212503 non-hodgkin's lymphoma 0.246332 nervous system lymphoma 0.742769 newly diagnosed primary 0.264174 therapy oncology group 0.22259	CLICK HERE
2007	National Cancer Institute	Html	es	Tratamiento de los tumores de células germinativas del sistema nervioso central infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores de células germinativas del sistema nervioso central infantil.	craniospinal irradiation 0.316255 germ-cell tumors 0.313995 intracranial germinoma 0.409628 cns germ cell 0.514596 Tumor Study Group 0.345102 LCR lumbar 0.316845 germ cell tumours 0.316685 with chemotherapy 0.342538 Japanese Pediatric Brain 0.336647 Patients With Newly 0.313535 Calaminus G 0.31314 Radiat Oncol Biol 0.37391 Pediatric Brain Tumor 0.404886 Younger Patients With 0.313094 newly diagnosed cns 0.31675 nongerminomatous germ cell 0.322146 central nervous system 0.442457 with chemotherapy followed 0.333351 cell tumor study 0.31798 primary chemotherapy 0.320021 patients with 0.448209 radiation therapy 0.332545 with central nervous 0.313181 chemotherapy followed 0.365679 chemotherapy with 0.323164	carcinoma embrionario 0.318514 nervous system germ 0.335764 SIOP CNS GCT 0.316308 Primary intracranial germ 0.315553 Matsutani M 0.312979 Neuro Oncol 0.319601 Pediatr Blood Cancer 0.338833 system germ cell 0.348752 focal primary site 0.31455 Clin Oncol 0.361515 saco vitelino 0.314073 sistema nervioso central 0.472998 Oncol Biol Phys 0.377556 Brain Tumor Study 0.347462 Bifocal intracranial germinoma 0.319163 patients with localized 0.323174 germ cell tumors 0.957656 newly diagnosed 0.329652 treated with 0.32552 Brain Tumor Consortium 0.321286 Childs Nerv Syst 0.319542 Oncology Group 0.314345 tumor study 0.348078 primary site irradiation 0.315366	CLICK HERE
2109	National Cancer Institute	Html	es	Prevención del cáncer de esófago (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre los factores que pueden influir en el riesgo de cáncer de esófago y sobre la investigación dirigida a la prevención de esta enfermedad.	siguientes factores 0.969759 voluntarios sanos 0.42115 Physician Data Query 0.489663 Estados Unidos 0.430297 libre uso 0.411941 suficiente ejercicio 0.429799 prevención revisa 0.420955	PDQ Prevención 0.433383 carcinoma epidermoide 0.463013 National Cancer Institute 0.420887 siguientes riesgos 0.416828 siguientes sumarios 0.467407 Instituto Nacional 0.441845	CLICK HERE
3461	National Cancer Institute	Html	es	Temas sobre terapias integrales, alternativas y complementarias (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos de información sobre las terapias integrales, alternativas y complementarias para personas con cáncer.	llamada lactobacillus acidophilus 0.320398 Sun’s Soup 0.3376 Flor Essence 0.384105 NCI Best Case 0.324965 Selected Vegetables 0.574814 sección suplementos 0.322686 vitamina d 0.319364 vitamina c 0.341075 sustancias químicas llamadas 0.324421 Unidos Selected Vegetables 0.324471 Instituto Nacional 0.442148 sección pectina 0.32118 Salud Complementaria 0.335148 pacientes náuseas 0.357085 coenzima q10 0.48743 PDQ Fatiga 0.398645 Health Interview Survey 0.325066 Estados Unidos 0.550173 sección complementos 0.349035 sección vitamina 0.346665 cardo mariano 0.387654 sección intervenciones 0.319196 punica granatum l 0.321333 sección intervención 0.343132 Centro Nacional 0.320165	sección ejercicio 0.33994 sección soja 0.320395 sección jengibre 0.320032 Sun's Soup 0.379451 sección té 0.319269 coenzima q10 ayuda 0.329386 hierba sonajero 0.430937 pacientes régimen gonzalez 0.360587 sección granada 0.318618 PDQ Temas 0.374069 salud náuseas 0.319268 pacientes linfedema 0.359299 San Juan 0.409901 sección licopeno 0.323612 sección tratamiento 0.563476 Physician Data Query 0.356925 sistema nervioso central 0.321486 enzimas pancreáticas 0.337252 cáncer renal 0.379726 sección terapia 0.318859 ¿El tratamiento 0.326217 sección selenio 0.319463 medicina complementaria 0.95764 terapia gerson 0.366138	CLICK HERE
15479	National Cancer Institute	Html	en	Intramural Investigators Submitting Data	Find general requirements for intramural investigators submitting genomic data. Different processes may exist based on operational differences in NCI intramural research programs.	dbGaP staff 0.612313 Institutional Certification 0.866347 review process 0.634188 accession number 0.623142 accuracy 0.439647 general requirements 0.674142 Institutional Review Board 0.856814 division 0.480859 Assignment 0.440982 NCI intramural research 0.909946 dbGaP Study Release 0.812896 DSPs 0.462568 initiation 0.444589 submission process 0.630778 Scientific Review 0.648183 contact 0.441788 human subjects 0.63038 studies 0.475426 required fields 0.609497 details 0.440138 expectations 0.502409 3. 0.437685 genomic data 0.866328	DSP 0.443274 data submission formats 0.913248 dbGaP submission 0.646264 study submission information 0.828375 Basic Study Information 0.823319 center 0.480797 operational differences 0.660458 different processes 0.658659 steps 0.441942 QA/QC Data Submission 0.891139 submission portal 0.629655 data generation completion 0.860975 plans 0.439922 IRB 0.460706 Data Generation Completed 0.868892 quality assurance check 0.803588 GPA 0.717674 project proposal 0.64122 programs 0.443042 time 0.4353 send 0.442857 de-identified human specimens 0.860465	CLICK HERE
16380	National Cancer Institute	Html	es	Toxicidad financiera del tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del riesgo de sufrir dificultades financieras durante el tratamiento del cáncer.	among patients with 0.356148 National Health Interview 0.33762 survivors identified through 0.3506 Guy GP Jr 0.797953 Targeted Cancer Therapies 0.346578 seguro médico 0.502578 Cancer Care Outcomes 0.395905 Medical Debt And 0.338028 Care Outcomes Research 0.337105 cancer care 0.484521 Adult Cancer Survivors 0.410356 Ekwueme DU 0.389597 estudio cancer care 0.350705 burden among 0.343127 Health Interview Survey 0.341695 Blough D 0.351854 Natl Cancer Inst 0.34743 cáncer versus 0.347441 Medicare Current Beneficiary 0.347647 cancer survivors 0.793538 Duke Cancer Institute 0.343096 with cancer 0.974917 patients with 0.384813 Medicare beneficiaries with 0.362941 Dowling EC 0.336978	Hardship Associated With 0.350445 United States 0.354013 financial hardship 0.453927 experiences with cancer 0.407883 Financial Hardship Associated 0.350297 Health Aff 0.447932 Care Cancer 0.350503 associated with cancer 0.462553 Debt And Bankruptcy 0.341472 Yabroff KR 0.591176 medical expenditure 0.337994 For Working-Age Cancer 0.400083 out-of-pocket health care 0.387866 Working-Age Cancer Survivors 0.410894 Clin Oncol 0.748582 breast cancer 0.503347 Rectal Cancer 0.343774 Non-elderly Cancer Survivors 0.355648 cáncer problemas 0.341283 financial toxicity 0.423332 patients receiving adjuvant 0.339287 MEPS Experiences with 0.352286 Current Beneficiary Survey 0.336425 expenditure burden 0.396505	CLICK HERE